US Patent Issued to NIPD GENETICS on Oct. 7 for "Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers" (Cypriot Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,374, issued on Oct. 7, was assigned to NIPD GENETICS PUBLIC COMPANY Ltd. (Nicosia, Cyprus).

"Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers" was invented by George Koumbaris (Lithrodontas, Cyprus), Marios Ioannides (Nicosia, Cyprus), Elena Kypri (Nicosia, Cyprus), Acilleas Achilleos (Limassol, Cyprus), Petros Mina (Nicosia, Cyprus), Alexia Eliades (Nicosia, Cyprus), Charalambos Loizides (Nicosia, Cyprus) and Philippos Patsalis (Nicosia, Cyprus).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods for assessment of tumor biomarkers using target-enriched multiplexed parallel analysis. The method...